timothy sykes logo
STXS Slides As Stereotaxis Clears Massive Secondary Share Block Thumbnail
G Google News

STXS Slides As Stereotaxis Clears Massive Secondary Share Block

TIM SYKES•UPDATED JUL. 19, 2026, 11:07 AM ET
Reviewed by Jack Kelloggand Fact-checked by Ellis Hobbs

Stereotaxis Inc. stocks have been trading down by -7.55 percent after news spotlighted delays and uncertainty in its robotic surgery pipeline.

What Traders Need To Know

  • Existing holders registered 19.45M shares for sale, creating a sizable potential secondary overhang.
  • A much larger 108.87M-share registration adds major supply risk if sellers step in aggressively.
  • The SEC filing allows resale of up to 108.9M shares, with Stereotaxis receiving no cash proceeds.
  • Recent trading shows sharp intraday volatility, suggesting the market is already responding to this supply shock.

Candlestick Chart

Weekly Update Jul 13 – Jul 17, 2026: On Sunday, July 19, 2026 Stereotaxis Inc. stock [NYSE American: STXS] is trending down by -7.55%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Healthcare industry expert:

Analyst sentiment – negative

Stereotaxis (STXS) occupies a niche position in robotic electrophysiology, with mid‑single‑digit revenue growth off a small $32.4M base and attractive 53.9% gross margin, but its fundamentals are weak. EBIT margin at roughly -71% and ROE around -266% highlight a structurally unprofitable model. Liquidity is adequate short term (current ratio 1.6, cash ~$14.6M), but free cash flow of -$3.5M in Q1 and heavy equity dependence signal ongoing dilution risk.

Technically, STXS trades as a low‑priced, thin‑volume name with sharp intraday swings. This week’s range (low ~$1.51, spike to ~$1.99, close ~$1.53–1.83) shows a failed breakout and sellers regaining control, consistent with a dominant down‑to‑sideways trend after the rejection near $2.00. Liquidity pockets cluster around $1.50 and $1.80. A precise actionable level: $1.50 is key support; any close below it invites momentum shorts toward $1.20, while $1.80 caps near‑term upside.

The recent registration to resell up to ~108.9M shares, with no proceeds to STXS, is a clear overhang, materially above the ~98–99M diluted share base and signaling substantial supply from legacy holders. Versus Healthcare and MedTech benchmarks, STXS screens far weaker on profitability, scale, and capital efficiency, trading at ~5.8x sales and ~12.7x book despite deep losses. Outlook is negative: expect pressure between $1.20 support and $2.00 resistance; fair value skews toward $1.25 absent rapid, credible path to profitability.

More Breaking News

Quick Financial Overview

Stereotaxis Inc. (STXS) just put a huge amount of stock on the shelf for existing holders. The registration of 19.45M shares plus another 108.87M shares signals potential selling pressure if those owners decide to exit. Because the company will not receive any cash from these resales, traders must treat this as a pure supply event, not a capital-raising move that strengthens the balance sheet.

On the numbers, Stereotaxis Inc. generated about $32.4M in annual revenue, with revenue growing modestly over several years. The gross margin near 53.9% shows the core product economics are solid, but operating margins are deeply negative, with EBIT margin around -71%. Returns on equity and assets are heavily in the red, reflecting a business still burning cash, even though the balance sheet has some support from $14.6M in cash and a current ratio around 1.6.

From a trading angle, STXS has been volatile. In recent days, the stock spiked from around $1.65 to an intraday high near $1.99 before fading back toward the mid-$1.50s. A 5‑minute candle showing a drop from the upper $1.80s into the mid-$1.50s in one bar points to aggressive selling and weak intraday support. When you combine this price action with the looming secondary blocks, rallies in Stereotaxis Inc. are likely to meet sellers quickly.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”